Paul Rennert | BiotechTV

top of page

Search

Oncology expert Paul Rennert gives an update on Aleta Biotherapeutics and previews some targets at #ASCO24

May 31, 2024

Oncology expert Paul Rennert gives an update on Aleta Biotherapeutics and previews some targets at #ASCO24

Paul Rennert talks about the first four patients who have been dosed in Aleta's clinical trial, as well as previewing targets such as...

Aleta Biotherapeutics' Paul Rennert on what he sees is working, and what isn't, at #SITC23

Nov 4, 2023

Aleta Biotherapeutics' Paul Rennert on what he sees is working, and what isn't, at #SITC23

Paul Rennert gives an update on Aleta, and summarizes data at #SITC23 from the IO 2.0, cytokine, TGF beta, Treg, lymphoid, and CAR-T spaces.

Watching cell therapy innovation at #ASCO23.

Jun 2, 2023

Watching cell therapy innovation at #ASCO23.

Paul Rennert of Aleta Biotherapeutics gives a rundown on the latest in cell therapies and other modalities ahead of #ASCO23.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.

Visit Savills' Life Sciences Overview

bottom of page